Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
monzon, eva m
STA-02, NCT04673461 / 2019-004943-54: Study Investigating STA363 Compared to Placebo in Patients With Chronic Discogenic Low Back Pain	Active, not recruiting	2	110	Europe, RoW	STA363 containing 90 mg (60 mg/mL) lactic acid, STA363 containing 180 mg (120 mg/mL) lactic acid, Placebo	Stayble Therapeutics, Stayble Therapeutics AB	Discogenic Pain	09/23	10/23
llanos, lucia
No trials found